FOXP3 and small cell lung carcinoma: The same study, including data from a cohort of 65 SCLC patients, demonstrated the presence of IL-15 in SCLC biopsies, and a positive correlation between increase in tumor infiltration of FOXP3 T-cells and worse OS [42], opening new avenues for future immune therapies against SCLC.